Top Sequana Medical Presentations
The most viewed presentations, reports, and documents from Sequana Medical.
Sequana Medical 2023 Investor Presentation
investor_presentationinvestor_presentation
52 Pages
Sequana Medical Investor Presentation 2023 Fluid Overload Treatment
investor_presentationinvestor_presentation
52 Pages
Sequana Medical 2023 BioCapital Europe Presentation
conferenceconference
21 Pages
Sequana Medical Investor Presentation 2021 Alfapump Ascites Treatment
investor_presentationinvestor_presentation
39 Pages
Sequana Medical Investor Presentation 2021
investor_presentationinvestor_presentation
39 Pages
Sequana Medical 2021 BioCapital Europe Presentation
investor_presentationinvestor_presentation
19 Pages
Sequana Medical 2021 Needham Virtual Healthcare Conference
conferenceconference
30 Pages
Sequana Medical Investor Presentation September 2021
investor_presentationinvestor_presentation
45 Pages
Sequana Medical Investor Presentation 2021 - Fluid Overload Treatment
investor_presentationinvestor_presentation
50 Pages
Sequana Medical Investor Presentation October 2021
investor_presentationinvestor_presentation
50 Pages
Sequana Medical Investor Presentation November 2021
investor_presentationinvestor_presentation
47 Pages
Sequana Medical Investor Presentation December 2021
investor_presentationinvestor_presentation
46 Pages
Sequana Medical 2022 Investor Presentation: Diuretic-Resistant Fluid Overload
investor_presentationinvestor_presentation
50 Pages
Sequana Medical Investor Presentation 2022
investor_presentationinvestor_presentation
27 Pages
Sequana Medical 2022 BTIG Virtual Conference Presentation
conferenceconference
27 Pages
Sequana Medical 2022 BioCapital Europe Investor Presentation
investor_presentationinvestor_presentation
27 Pages
Sequana Medical 2022 Oppenheimer Healthcare Conference
conferenceconference
27 Pages
Sequana Medical 2022 Needham Healthcare Conference Presentation
conferenceconference
27 Pages
Sequana Medical H.C. Wainwright Conference 2022
conferenceconference
27 Pages
Sequana Medical Investor Presentation 2022 - Drug-Resistant Fluid Overload Treatment
investor_presentationinvestor_presentation
49 Pages